| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |